Data Management and Insight Generation
Multiomic data management and insight generation are now central to oncology drug development, yet the process has become increasingly complex and fragmented. Vast, heterogeneous datasets spanning genomics, transcriptomics, proteomics, and clinical data demand sophisticated cleansing, integration, and unification to ensure quality and interoperability. Farcast's capabilities can help address the challenge by delivering robust data pipelines, intuitive visualizations, and advanced analytical frameworks that turn raw data into cohesive insight.
Our experts have experience with cutting-edge machine learning models for biomarker discovery, patient stratification, and therapeutic response prediction, bridging the gap between computation and biology. With a proven record of executing multiple biomarker discovery collaborations with oncology R&D teams, we combine scientific depth, translational understanding, and data and AI/ML know how to unlock the full potential of multiomics in precision oncology.
Multiomic Data Management
End-to-end data support – from raw data cleansing and quality control to advanced multiomic integration and interpretation
​
Published data integration – harmonize data with leading public multiomics and oncology resources to strengthen findings and generate translational hypotheses
Advanced visualization – intuitive, interactive dashboards that enable rapid understanding of complex, high-dimensional data
Insight Generation
​
Proprietary data overlays – augment datasets with Farcast’s unique reference cohorts and curated oncology datasets for deeper biological insights
Tailored biomarker discovery – machine learning and AI models to identify predictive and prognostic biomarkers in pre-clinical and early clinical studies
AI-driven feature extraction – uncover hidden molecular patterns linked to mechanism of action, drug response, and resistance pathways